THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ABION INC, ICGEB and PROVIDENCE HEALTH & SERVICES OREGON.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 9 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Organic fine chemistry | |
#6 | Medical technology | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Climate change adaptation technologies | |
#8 | Sugars | |
#9 | Enzymes | |
#10 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Felber Barbara K | 4 |
#2 | Pavlakis George N | 4 |
#3 | Nichol Stuart T | 3 |
#4 | Leppla Stephen H | 2 |
#5 | Pfister Thomas D | 2 |
#6 | Berman Lashondra | 2 |
#7 | Wu Kai-Hui | 2 |
#8 | Warnes Christine | 2 |
#9 | Lane David | 2 |
#10 | Lindstrom Stephen | 2 |
Publication | Filing date | Title |
---|---|---|
WO2017177063A1 | Use of heterodimeric il-15 in adoptive cell transfer | |
WO2017161169A1 | Anti-py1235-met immunological binding reagent | |
WO2017106184A2 | Detection of live attenuated influenza vaccine viruses | |
WO2017008056A1 | Enhancing astrocyte neuroprotective functions using p53 isoforms | |
WO2016196366A1 | Extension of replicative lifespan in diseases of premature aging using p53 isoforms | |
WO2016183420A1 | Methods and compositions for inducing an immune response using conserved element constructs | |
WO2016154623A2 | Anti-cd133 monoclonal antibodies and related compositions and methods | |
US2015306202A1 | Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus | |
US2015196630A1 | Rift valley fever virus replicon particles and use thereof | |
US2015086577A1 | Pathogenic phlebovirus isolates and compositions and methods of use | |
US2015133329A1 | Methods of detecting influenza virus | |
US2015056237A1 | Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conserved regions |